1,10-Phenanthroline

Alternative names

28 kDa heat shock protein, 82 kDa matrix metalloproteinase-9, 92 kDa gelatinase, 92 kDa type IV collagenase, ACEE, ACES_HUMAN, ACLS, AHR_HUMAN, AI838772, AIS, AM4 7, AML 1, AML1 EVI 1, AML1 EVI 1 fusion protein, AMLCR 1, ANDR_HUMAN, AP-1, AR, AR8, ARACHE, ARNT-interacting protein, ARO, ARO1, ATAD5_HUMAN, ATPase family AAA domain containing 5, ATPase family AAA domain-containing protein 5, AW493413, Acetylcholinesterase, Activator protein 1, Acute myeloid leukemia 1, Acute myeloid leukemia 1 protein, Ah receptor, Aml1 oncogene, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease), Antigen NY-CO-13, Apoptosis related acetylcholinesterase, Aromatase, Aromatic hydrocarbon receptor, Aryl hydrocarbon receptor, Aryl hydrocarbon receptor precursor, Atherosclerosis, susceptibility to, included, BAR, BAZ2B_HUMAN, BCC7, BXR, Basic-helix-loop-helix-PAS protein MOP1, Bile acid receptor, Bromodomain adjacent to zinc finger domain 2B, Bromodomain adjacent to zinc finger domain protein 2B, C-C CKR-5, C-C chemokine receptor type 5, C-C motif chemokine receptor 5 A159A, C17orf41, CAR, CAR BETA, CARA, CBF b, CBF-alpha-2, CBF-beta, CBFA 2, CC Chemokine Receptor 5, CCR5 chemokine (C C motif) receptor 5, CCR5_HUMAN, CD 195, CD195 Antigen, CHEMR13, CKR 5, CLG 1, CLG 3, CLG 4B, CMKBR 5, CMT2F, CP19A_HUMAN, CPV1, CYAR, CYP19, CYPXIX, Car 1, Cellular tumor antigen p53, Chemokine C C motif receptor 5, Chemokine receptor CCR5, Chromosome fragility-associated gene 1 protein, Class E basic helix-loop-helix protein 76, Class E basic helix-loop-helix protein 78, Collagenase 1, Collagenase 1 neutrophil, Collagenase 3, Collagenase Type 4 beta, Collagenase type IV 92 KD, Constitutive activator of retinoid response, Constitutive active response, Constitutive androstane receptor, Core binding factor alpha 2 subunit, Core binding factor beta subunit, Core binding factor runt domain alpha subunit 2, Core-binding factor subunit alpha-2, Core-binding factor subunit beta, Core-binding factor, beta subunit (CBFB), transcript variant 2, Cyp19a1, Cytochrome P-450AROM, Cytochrome P450 19A1, Cytochrome P450, family 19, subfamily A, polypeptide 1, Cytochrome P450, subfamily XIX (aromatization of androgens), Cytosolic NADP-isocitrate dehydrogenase, DHTR, DKFZp434H071, DKFZp586P1322, DKFZp686N23123, DKFZp762I0516, DNA binding protein, Dihydro testosterone receptor, Dihydrotestosterone receptor (DHTR), EC 3.4.24.35, ELG1, ER, ER-alpha, ER-beta, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESR2_HUMAN, ESRA, ESRL 1, ESRR A, ESTR B, Enhanced level of genomic instability 1 homolog, Enhancer Binding Protein AP1, Epididymis luminal protein 216, Epididymis secretory protein Li 26, Era, Erb, Erb2, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta, Estrogen receptor beta 4, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen resistance, included, Estrogen synthase, Estrogen synthetase, Estrogen-regulated 24 kDa protein, Estrogen-related receptor alpha, Estrra, FK506 binding protein 12 rapamycin associated protein 1, FK506 binding protein 12 rapamycin associated protein 2, FK506-binding protein 12-rapamycin complex-associated protein 1, FKBP rapamycin associated protein, FKBP12-rapamycin complex-associated protein, FKBP12-rapamycin complex-associated protein 1, FLJ11090, FLJ44809, FLJ45644, FLJ78003, FLJ92943, FRAG1, FRAP, FRAP1, FRAP2, FXR, Farnesoid X receptor, Farnesoid X-activated receptor, Farnesol receptor HRR-1, GCPS, GELB, GLI Kruppel family member GLI 3, GLI Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome), GLI family zinc finger 3, GLI3 C-terminally truncated form, GLI3 form of 190 kDa, GLI3 form of 83 kDa, GLI3 full length protein, GLI3-190, GLI3-83, GLI3FL, GLI3_HUMAN, Gelatinase 92 KD, Gelatinase B, Gelatinase beta, Glioma associated oncogene family zinc finger 3, HD 7, HD 7B, HD 9, HDAC, HDAC 7B, HDAC 9B, HDAC 9FL, HDAC9_HUMAN, HDL cholesterol, augmented response of, to hormone replacement, included, HDRP, HEL-216, HEL-S-102, HEL-S-26, HGNC, HGNC:348, HIF-1, HIF-1-alpha, HIF-alpha, HIF1A_HUMAN, HIV-1 fusion coreceptor, HMN2B, HNC, HRR 1, HS.76067, HS90A_HUMAN, HSP 27, HSP 84, HSP 86, HSP 90, HSP 90 b, HSP90A, HSP90AA1, HSP90AB1, HSPB1_HUMAN, HSPC1, HSPC2, HSPCAL1, HSPCAL4, HUMARA, HYSP1, Heat Shock Protein 27, Heat shock 25kDa protein 1, Heat shock 27 kDa protein, Heat shock 27kD protein 1, Heat shock 27kDa protein 1, Heat shock 28kDa protein 1, Heat shock 86 kDa, Heat shock protein 90kDa alpha cytosolic class A member 1, Heat shock protein 90kDa alpha cytosolic class B member 1, Heat shock protein HSP 90-alpha, Heat shock protein HSP 90-beta, Heat shock protein beta-1, Histone deacetylase 4/5 related protein, Histone deacetylase 7, Histone deacetylase 7B, Histone deacetylase 9, Histone deacetylase 9A, Histone deacetylase-related protein, Hsp 25, Hsp 28, Hypoxia inducible factor 1 alpha isoform I.3, Hypoxia inducible factor 1 alpha subunit, Hypoxia inducible factor 1 alpha subunit basic helix loop helix transcription factor, Hypoxia inducible factor 1, alpha subunit (basic helix loop helix transcription factor), Hypoxia-inducible factor 1-alpha, ICDH, IDCD, IDDM22, IDH, IDH1, IDHC_HUMAN, IDP, IDPC, IMD42, Isocitrate dehydrogenase (NADP(+)) 1 cytosolic, Isocitrate dehydrogenase 1 (NADP+) soluble, Isocitrate dehydrogenase [NADP] cytoplasmic, JUN protein, JUNC, JUN_HUMAN, Jun Activation Domain Binding Protein, Jun oncogene, Jun proto oncogene, KD, KIAA0744, Kennedy disease (KD), LFS1, MANDP1, MANDP2, MB67, MEF2 interacting transcription repressor protein, MEF2-interacting transcription repressor MITR, MGC104252, MGC104309, MGC112732, MGC129539, MGC97144, MIP-1 alpha receptor, MITR, MMP13_HUMAN, MMP8_HUMAN, MMP9_HUMAN, MOP 1, MTOR_HUMAN, Macrophage gelatinase, Mammalian target of rapamycin, Matrix Metalloproteinase 9, Matrix metallopeptidase 13 (collagenase 3), Matrix metallopeptidase 8 (neutrophil collagenase), Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase), Matrix metalloprotease 8, Matrix metalloproteinase-13, Matrix metalloproteinase-8, Mechanistic target of rapamycin, Member of PAS protein 1, Member of PAS superfamily 1, Member of the PAS Superfamily 1, Microsomal monooxygenase, Mutant tumor protein 53, Myocardial infarction, susceptibility to, included, N-ACHE, NADP dependent isocitrate dehydrogenase cytosolic, NADP dependent isocitrate dehydrogenase peroxisomal, NADP(+)-specific ICDH, NR1B1, NR1C3, NR1F3, NR1H4_HUMAN, NR1I2_HUMAN, NR1I3_HUMAN, NR3A1, NR3A2, NR3B1, NR3C3, NR3C4, Neutrophil collagenase, Nuclear mitotic apparatus protein retinoic acid receptor alpha fusion protein, Nuclear receptor ROR-gamma, Nuclear receptor RZR-gamma, Nuclear receptor subfamily 1 group B member 1, Nuclear receptor subfamily 1 group C member 3, Nuclear receptor subfamily 1 group F member 3, Nuclear receptor subfamily 1 group H member 4, Nuclear receptor subfamily 1 group I member 2, Nuclear receptor subfamily 1 group I member 3, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, Nuclear receptor subfamily 3 group B member 1, Nuclear receptor subfamily 3 group C member 3, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), Nucleophosmin retinoic acid receptor alpha fusion protein NPM RAR long form, ONR 1, OTTHUMP00000001983, OTTHUMP00000017718, OTTHUMP00000017719, OTTHUMP00000108696, OTTHUMP00000108697, OTTHUMP00000108699, OTTHUMP00000108700, OTTHUMP00000108702, OTTHUMP00000162543, OTTHUMP00000162897, OTTHUMP00000162898, OTTHUMP00000198350, OTTHUMP00000215173, OTTHUMP00000215174, OTTHUMP00000215175, Oncogene AML-1, Oncogene GLI3, Oncogene JUN, Orphan nuclear receptor MB67, Orphan nuclear receptor NR1I3, Orphan nuclear receptor PAR 1, Orphan nuclear receptor PXR, Oxalosuccinate decarboxylase, P 450AROM, P53_HUMAN, PAP A, PAPB, PAR, PAR q, PAS domain-containing protein 8, PASD 8, PEA 2, PEA2-alpha B, PEA2-beta, PEBB_HUMAN, PEBP 2B, PEBP2-alpha B, PEBP2-beta, PEBP2A2, PEBP2aB, PGR, PICD, PMNL collagenase, PMNL-CL, PPAR-gamma, PPARG2, PPARG_HUMAN, PPD IV, PR, PRA, PRB, PRGR_HUMAN, PRR, Peroxisome proliferator activated receptor gamma 2, Peroxisome proliferator-activated receptor gamma, Phosphoprotein p53, Polyomavirus enhancer-binding protein 2 alpha B subunit, Polyomavirus enhancer-binding protein 2 beta subunit, Pregnane X receptor, Progesterone receptor, Progestin receptor form A, Progestin receptor form B, Proto-oncogene c-jun, RAFT1, RAPT1, RAR, RAR related orphan nuclear receptor variant 2, RAR related orphan receptor C, isoform a, RAR related orphan receptor gamma, RAR-alpha, RAR-related orphan receptor C, RARA_HUMAN, RARalpha1, RIP 14, RNESTROR, RORG_HUMAN, RP24-311F12.2, RUNX1_HUMAN, RXR-interacting protein 14, RZR GAMMA, RZRG, Rapamycin and FKBP12 target 1, Rapamycin associated protein FRAP2, Rapamycin target protein, Rapamycin target protein 1, Renal carcinoma antigen NY-REN-38, Retinoic acid binding receptor gamma, Retinoic acid nuclear receptor alpha variant 1, Retinoic acid nuclear receptor alpha variant 2, Retinoic acid receptor alpha, Retinoic acid receptor alpha polypeptide, Retinoid X receptor-interacting protein 14, Retinoid-related orphan receptor-gamma, Rorc, Run1, Runt-related transcription factor 1, SBMA, SCAN1, SL3 3 enhancer factor 1 beta subunit, SL3-3 enhancer factor 1 alpha B subunit, SL3-3 enhancer factor 1 subunit beta, SL3/AKV core-binding factor alpha B subunit, SL3/AKV core-binding factor beta subunit, SMAX1, SRP27, SXR, Serine/threonine-protein kinase mTOR, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), Steroid and xenobiotic receptor, Steroid hormone receptor ERR1, Stress-responsive protein 27, TFM, TOR, TRP53, TYDP, TYDP1_HUMAN, Testicular Feminization (TFM), Tp53, Transcription factor AP-1, Transcriptional activator GLI3, Transcriptional repressor GLI3R, Transformation related protein 53, Tumor protein 53, Tumor protein p53, Tumor suppressor p53, Type V collagenase, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, V jun sarcoma virus 17 oncogene homolog, V jun sarcoma virus 17 oncogene homolog (avian), V-jun avian sarcoma virus 17 oncogene homolog, WALp4, YT, YT blood group, Zinc finger protein GLI 3, alpha subunit core binding factor, androgen receptor splice variant 4b, bHLHe76, bHLHe78, cJun, chromosome fragility associated gene 1, constitutive active receptor, constitutive androstane nuclear receptor variant 2, constitutive androstane nuclear receptor variant 3, constitutive androstane nuclear receptor variant 4, constitutive androstane nuclear receptor variant 5, dJ576K7.1 (FK506 binding protein 12 rapamycin associated protein 1), epididymis secretory protein Li 102, estrogen nuclear receptor beta variant a, estrogen nuclear receptor beta variant b, estrogen receptor related receptor alpha, flavoprotein-linked monooxygenase, hERR1, hWALp4, heat shock protein family B (small) member 1, hifla, orphan nuclear hormone receptor, p39, p53 tumor suppressor, pregnane X nuclear receptor variant 2, tumor antigen p55